A model calibrated to Papua New Guinea found self-collected HPV screen-and-treat more effective and more cost-effective than visual inspection with acetic acid, and estimated it could prevent 23,000 to 29,000 deaths over 50 years if scaled to 70% coverage from 2023.
The authors note that Papua New Guinea has a high burden of cervical cancer but no national cervical screening programme. They calibrated the Policy1-Cervix model to the country, compared 38 strategies of self-collected HPV screen-and-treat and visual inspection with acetic acid (VIA), and estimated effectiveness, cost-effectiveness and budget impact, assuming HPV testing cost US$18.
It gives Papua New Guinea its own estimate of what a national HPV screen-and-treat programme could achieve and what it would cost.
Shares National Department of Health, Papua New Guinea, HPV DNA testing and self-sampling, Cervical cancer.
Shares National Department of Health, Papua New Guinea, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/